Endozepines in recurrent stupor

Pietro Cortelli, Rossella Avallone, Mario Baraldi, Maria Luisa Zeneroli, Jessica Mandrioli, Lorenzo Corsi, Roberto Riva, Paolo Tinuper, Elio Lugaresi, Agostino Baruzzi, Pasquale Montagna

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Stupor is a condition from which the subject can be aroused only by vigorous stimuli. Most patients with stupor have a diffuse organic cerebral dysfunction. Rarely stupor is recurrent and no specific causes can be found. Patients with idiopathic recurrent stupor were awakened by i.v. administration of an antagonist (flumazenil) of the benzodiazepine recognition site located in the GABAA receptor. Since no exogenous benzodiazepines were detected in plasma and cerebrospinal fluid by high performance liquid chromatography, an excess of endogenous benzodiazepine-like compounds (endozepines) was proposed as the cause of stupor. The existence of endozepines, their widespread distribution in the CNS and their involvement in hepatic encephalopathy are established. However, the origin of these compounds, how biosynthesis occurs and the mechanisms and causes through which they alter brain functions are poorly understood. The fact that a number of synthetic benzodiazepines are difficult to detect using conventional techniques and the discovery that some cases of recurrent stupor were caused by fraudulent administration of lorazepam question whether the concept of endozepine recurrent stupor can be sustained. This review summarizes the state of endozepine physiology and pharmacology and the clinical syndromes attributed to their involvement. A diagnostic work-up to define endozepine-induced recurrent stupor is suggested.

Original languageEnglish
Pages (from-to)477-487
Number of pages11
JournalSleep Medicine Reviews
Volume9
Issue number6
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Diazepam Binding Inhibitor
Stupor
Benzodiazepines
Lorazepam
Flumazenil
Hepatic Encephalopathy
Clinical Pharmacology
GABA-A Receptors
Cerebrospinal Fluid
High Pressure Liquid Chromatography

Keywords

  • Benzodiazepines
  • Endozepines
  • Hepatic encephalopathy
  • Idiopathic recurrent stupor

ASJC Scopus subject areas

  • Clinical Neurology
  • Dentistry(all)
  • Ophthalmology
  • Pulmonary and Respiratory Medicine
  • Neurology

Cite this

Cortelli, P., Avallone, R., Baraldi, M., Zeneroli, M. L., Mandrioli, J., Corsi, L., ... Montagna, P. (2005). Endozepines in recurrent stupor. Sleep Medicine Reviews, 9(6), 477-487. https://doi.org/10.1016/j.smrv.2005.07.003

Endozepines in recurrent stupor. / Cortelli, Pietro; Avallone, Rossella; Baraldi, Mario; Zeneroli, Maria Luisa; Mandrioli, Jessica; Corsi, Lorenzo; Riva, Roberto; Tinuper, Paolo; Lugaresi, Elio; Baruzzi, Agostino; Montagna, Pasquale.

In: Sleep Medicine Reviews, Vol. 9, No. 6, 12.2005, p. 477-487.

Research output: Contribution to journalArticle

Cortelli, P, Avallone, R, Baraldi, M, Zeneroli, ML, Mandrioli, J, Corsi, L, Riva, R, Tinuper, P, Lugaresi, E, Baruzzi, A & Montagna, P 2005, 'Endozepines in recurrent stupor', Sleep Medicine Reviews, vol. 9, no. 6, pp. 477-487. https://doi.org/10.1016/j.smrv.2005.07.003
Cortelli P, Avallone R, Baraldi M, Zeneroli ML, Mandrioli J, Corsi L et al. Endozepines in recurrent stupor. Sleep Medicine Reviews. 2005 Dec;9(6):477-487. https://doi.org/10.1016/j.smrv.2005.07.003
Cortelli, Pietro ; Avallone, Rossella ; Baraldi, Mario ; Zeneroli, Maria Luisa ; Mandrioli, Jessica ; Corsi, Lorenzo ; Riva, Roberto ; Tinuper, Paolo ; Lugaresi, Elio ; Baruzzi, Agostino ; Montagna, Pasquale. / Endozepines in recurrent stupor. In: Sleep Medicine Reviews. 2005 ; Vol. 9, No. 6. pp. 477-487.
@article{f024be040800482cb3f4e017e8d7608a,
title = "Endozepines in recurrent stupor",
abstract = "Stupor is a condition from which the subject can be aroused only by vigorous stimuli. Most patients with stupor have a diffuse organic cerebral dysfunction. Rarely stupor is recurrent and no specific causes can be found. Patients with idiopathic recurrent stupor were awakened by i.v. administration of an antagonist (flumazenil) of the benzodiazepine recognition site located in the GABAA receptor. Since no exogenous benzodiazepines were detected in plasma and cerebrospinal fluid by high performance liquid chromatography, an excess of endogenous benzodiazepine-like compounds (endozepines) was proposed as the cause of stupor. The existence of endozepines, their widespread distribution in the CNS and their involvement in hepatic encephalopathy are established. However, the origin of these compounds, how biosynthesis occurs and the mechanisms and causes through which they alter brain functions are poorly understood. The fact that a number of synthetic benzodiazepines are difficult to detect using conventional techniques and the discovery that some cases of recurrent stupor were caused by fraudulent administration of lorazepam question whether the concept of endozepine recurrent stupor can be sustained. This review summarizes the state of endozepine physiology and pharmacology and the clinical syndromes attributed to their involvement. A diagnostic work-up to define endozepine-induced recurrent stupor is suggested.",
keywords = "Benzodiazepines, Endozepines, Hepatic encephalopathy, Idiopathic recurrent stupor",
author = "Pietro Cortelli and Rossella Avallone and Mario Baraldi and Zeneroli, {Maria Luisa} and Jessica Mandrioli and Lorenzo Corsi and Roberto Riva and Paolo Tinuper and Elio Lugaresi and Agostino Baruzzi and Pasquale Montagna",
year = "2005",
month = "12",
doi = "10.1016/j.smrv.2005.07.003",
language = "English",
volume = "9",
pages = "477--487",
journal = "Sleep Medicine Reviews",
issn = "1087-0792",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Endozepines in recurrent stupor

AU - Cortelli, Pietro

AU - Avallone, Rossella

AU - Baraldi, Mario

AU - Zeneroli, Maria Luisa

AU - Mandrioli, Jessica

AU - Corsi, Lorenzo

AU - Riva, Roberto

AU - Tinuper, Paolo

AU - Lugaresi, Elio

AU - Baruzzi, Agostino

AU - Montagna, Pasquale

PY - 2005/12

Y1 - 2005/12

N2 - Stupor is a condition from which the subject can be aroused only by vigorous stimuli. Most patients with stupor have a diffuse organic cerebral dysfunction. Rarely stupor is recurrent and no specific causes can be found. Patients with idiopathic recurrent stupor were awakened by i.v. administration of an antagonist (flumazenil) of the benzodiazepine recognition site located in the GABAA receptor. Since no exogenous benzodiazepines were detected in plasma and cerebrospinal fluid by high performance liquid chromatography, an excess of endogenous benzodiazepine-like compounds (endozepines) was proposed as the cause of stupor. The existence of endozepines, their widespread distribution in the CNS and their involvement in hepatic encephalopathy are established. However, the origin of these compounds, how biosynthesis occurs and the mechanisms and causes through which they alter brain functions are poorly understood. The fact that a number of synthetic benzodiazepines are difficult to detect using conventional techniques and the discovery that some cases of recurrent stupor were caused by fraudulent administration of lorazepam question whether the concept of endozepine recurrent stupor can be sustained. This review summarizes the state of endozepine physiology and pharmacology and the clinical syndromes attributed to their involvement. A diagnostic work-up to define endozepine-induced recurrent stupor is suggested.

AB - Stupor is a condition from which the subject can be aroused only by vigorous stimuli. Most patients with stupor have a diffuse organic cerebral dysfunction. Rarely stupor is recurrent and no specific causes can be found. Patients with idiopathic recurrent stupor were awakened by i.v. administration of an antagonist (flumazenil) of the benzodiazepine recognition site located in the GABAA receptor. Since no exogenous benzodiazepines were detected in plasma and cerebrospinal fluid by high performance liquid chromatography, an excess of endogenous benzodiazepine-like compounds (endozepines) was proposed as the cause of stupor. The existence of endozepines, their widespread distribution in the CNS and their involvement in hepatic encephalopathy are established. However, the origin of these compounds, how biosynthesis occurs and the mechanisms and causes through which they alter brain functions are poorly understood. The fact that a number of synthetic benzodiazepines are difficult to detect using conventional techniques and the discovery that some cases of recurrent stupor were caused by fraudulent administration of lorazepam question whether the concept of endozepine recurrent stupor can be sustained. This review summarizes the state of endozepine physiology and pharmacology and the clinical syndromes attributed to their involvement. A diagnostic work-up to define endozepine-induced recurrent stupor is suggested.

KW - Benzodiazepines

KW - Endozepines

KW - Hepatic encephalopathy

KW - Idiopathic recurrent stupor

UR - http://www.scopus.com/inward/record.url?scp=27744536449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744536449&partnerID=8YFLogxK

U2 - 10.1016/j.smrv.2005.07.003

DO - 10.1016/j.smrv.2005.07.003

M3 - Article

C2 - 16233983

AN - SCOPUS:27744536449

VL - 9

SP - 477

EP - 487

JO - Sleep Medicine Reviews

JF - Sleep Medicine Reviews

SN - 1087-0792

IS - 6

ER -